New Jersey bills · 2026-2027 Regular Session
New Jersey A 1510
Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Freiman, Roy (Democratic)
- Stanley, Sterley S. (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jun 4, 2026): Reported out of Assembly Comm. with Amendments, 2nd Reading
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jun 4, 2026 · House
Reported out of Assembly Comm. with Amendments, 2nd Reading - Jan 13, 2026 · House
Introduced, Referred to Assembly Financial Institutions and Insurance Committee